×
0 0 0 0 0.00358422939068109 0.00179211469534046 0.0197132616487456 0.0125448028673836
Stockreport

Will 2018 Be Celldex Therapeutics, Inc.'s Best Year Yet? [The Motley Fool]

CELLDEX THERAPEUTICS (CLDX)  More Company Research Source: The Motley Fool
Last celldex therapeutics earnings: 5/10 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.celldex.com
PDF Celldex Therapeutics stock might double within the next six months. Here's why. Wall Street thinks that the clinical-stage biotech Celldex Therapeutics ( NASDAQ:CLDX ) could be a top-performing stock this year. The average 12-month price target on the stock, after all, implies a noteworthy 260% upside potential from current levels.   Why are some analysts so excited about this small-cap biotech stock? The big ticket item, if you will, is the upcoming top-line data readout for the company's experimental breast cancer drug, glembatumumab vedotin , or glemba for short. The heart of the matter is that a successful trial result here has the potential to transform Celldex into a cash flow positive operation within a few short years. Image source: Getty Images. As clinical trials are inherently risky endeavors, however, investors need to carefully weigh the benefits of a positive outcome in this trial, versus the downside risk that would come with a failure. So, wi [Read more]

IMPACT SNAPSHOT EVENT TIME: CLDX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS